Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage

被引:42
作者
Parker, E. A.
Hegde, A.
Buckley, M.
Barnes, K. M.
Baron, J.
Nilsson, O.
机构
[1] NICHHD, NIH, Dev Endocrinol Branch, Bethesda, MD 20892 USA
[2] Karolinska Univ Hosp, Karolinska Inst, Pediat Endocrinol Unit, Dept Woman & Child Hlth, SE-17176 Stockholm, Sweden
关键词
D O I
10.1677/JOE-07-0012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies of the GH-IGF system gene expression in growth plate using immunohistochemistry and in situ hybridization have yielded conflicting results. We therefore studied the spatial and temporal patterns of mRNA expression of the GHIGF system in the rat proximal tibial growth plate quantitatively. Growth plates were rnicrodissected into individual zones. RNA was extracted, reverse transcribed and analyzed by real-time PCR. In 1-week-old animals, IGF-I mRNA expression was minimal in growth plate compared with perichondrium, metaphyseal bone, muscle, and liver (70-, 130-, 215-, and 400-fold less). In contrast, IGF-II mRNA was expressed at higher levels than in bone and liver (65- and 2-fold). IGF-II expression was higher in the proliferative and resting zones compared with the hypertrophic zone (P < 0-001). GH receptor and type 1 and 2 IGF receptors were expressed throughout the growth plate. Expression of IGF-binding proteins (IGFBPs)-1 through -6 mPNA was low throughout the growth plate compared with perichondriurn and bone. With increasing age (3-, 6-, 9-, and 12-week castrated rats), IGF-I mRNA levels increased in the proliferative zone (PZ) but remained at least tenfold lower than levels in perichondriurn and bone. IGF-II mRNA decreased dramatically in PZ (780-fold; P<0-001) whereas, type 2 IGF receptor and IGFBP-1, IGFBP-2, IGFBP-3, and IGFBP-4 increased significantly with age in growth plate and/or surrounding perichondrium and bone. These data suggest that IGF-I protein in the growth plate is not produced primarily by the chondrocytes themselves. Instead, it derives from surrounding perichondrium and bone. In addition, the decrease in growth velocity that occurs with age may be caused, in part, by decreasing expression of IGF-II and increasing expression of type 2 IGF receptor and multiple IGFBPs.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 37 条
  • [1] The role of the resting zone in growth plate chondrogenesis
    Abad, V
    Meyers, JL
    Weise, M
    Gafni, RI
    Barnes, KM
    Nilsson, O
    Bacher, JD
    Baron, J
    [J]. ENDOCRINOLOGY, 2002, 143 (05) : 1851 - 1857
  • [2] β1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis
    Aszodi, A
    Hunziker, EB
    Brakebusch, C
    Fässler, R
    [J]. GENES & DEVELOPMENT, 2003, 17 (19) : 2465 - 2479
  • [3] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [4] BROWN AL, 1986, J BIOL CHEM, V261, P3144
  • [5] Growth hormone axis overview - somatomedin hypothesis
    Daughaday, WH
    [J]. PEDIATRIC NEPHROLOGY, 2000, 14 (07) : 537 - 540
  • [6] VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
    Gerber, HP
    Vu, TH
    Ryan, AM
    Kowalski, J
    Werb, Z
    Ferrara, N
    [J]. NATURE MEDICINE, 1999, 5 (06) : 623 - 628
  • [7] Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate
    Gevers, EF
    Van Der Eerden, BCJ
    Karperien, M
    Raap, AK
    Robinson, ICAF
    Wit, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (08) : 1408 - 1419
  • [8] Gevers EF, 1996, J BONE MINER RES, V11, P1103
  • [9] DEXAMETHASONE INCREASES GROWTH-HORMONE RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS IN LIVER AND GROWTH-PLATE
    HEINRICHS, C
    YANOVSKI, JA
    ROTH, AH
    YU, YM
    DOMENE, HM
    YANO, K
    CUTLER, GB
    BARON, J
    [J]. ENDOCRINOLOGY, 1994, 135 (03) : 1113 - 1118
  • [10] DIFFERENTIAL-EFFECTS OF INSULIN-LIKE GROWTH-FACTOR-I AND GROWTH-HORMONE ON DEVELOPMENTAL STAGES OF RAT GROWTH-PLATE CHONDROCYTES IN-VIVO
    HUNZIKER, EB
    WAGNER, J
    ZAPF, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) : 1078 - 1086